The in-vitro antimicrobial activity of some traditionally used medicinal plants against beta-lactam-resistant bacteria

Journal of Infection in Developing Countries

Volumn 3, Issue 9, 2009, Pages 671-680

  Gangoué Piéboji, Joseph ^a,b   Eze, Noelly ^c   Djintchui, Arnaud Ngongang ^c   Ngameni, Bathélémy ^c   Tsabang, Nolé ^a   Pegnyemb, Dieudonné E ^c   Biyiti, Lucie ^a   Ngassam, Pierre ^c   Koulla Shiro, Sinata ^c   Galleni, Moreno ^b  

^a Institute of Medical Research and Medicinal Plant Studies   (Cameroon)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c UNIVERSITY OF YAOUNDÉ I   (Cameroon)

Author keywords

Antimicrobial activity; Beta lactam resistant bacteria; Beta lactamase; Cameroon; Medicinal plant

Indexed keywords

ADENIA LOBATA EXTRACT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; AZTREONAM; BARTERIA FISTULOSA EXTRACT; BETA LACTAM ANTIBIOTIC; BRIDELIA MICRANTHA EXTRACT; CAMPYLOBACTER EXCAVATUM EXTRACT; CAMPYLOSPERMUM DENSIFLORUM EXTRACT; CAMPYLOSPERMUM ZENKERI EXTRACT; CEFALOTIN; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; DORTENIA PICTA EXTRACT; GARCINIA KOLA EXTRACT; GARCINIA LUCIDA EXTRACT; GENTAMICIN; IMIPENEM; MALLOTUS OPPOSITIFOLIUS EXTRACT; PICRALINA NITIDA EXTRACT; PIPERACILLIN; PLANT EXTRACT; PYGEUM AFRICANUM EXTRACT; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ADENIA LOBATA; AGAR DILUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BARK; BARTERIA FISTULOSA; BRIDELIA MICRANTHA; CAMPYLOBACTER EXCAVATUM; CAMPYLOSPERMUM DENSIFLORUM; CAMPYLOSPERMUM ZENKERI; CONTROLLED STUDY; DISK DIFFUSION; DORSTENIA PICTA; DRUG ISOLATION; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROCOCCUS HIRAE; ESCHERICHIA COLI; EUPHORBIA; GARCINIA; GARCINIA LUCIDA; IN VITRO STUDY; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MALLOTUS OPPOSITIFOLIUS; MEDICINAL PLANT; MINIMUM INHIBITORY CONCENTRATION; MORACEAE; NONHUMAN; OCHNACEAE; PASSION FRUIT; PICRALINA NITIDA; PLANT LEAF; PLANT ROOT; PLANT SEED; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS SAPROPHYTICUS;

ACINETOBACTER BAUMANNII; BACILLI (CLASS); BACTERIA (MICROORGANISMS); BRIDELIA MICRANTHA; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROCOCCUS HIRAE; ENTEROCOCCUS SP.; ESCHERICHIA COLI; GARCINIA; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MALLOTUS OPPOSITIFOLIUS; NEGIBACTERIA; POSIBACTERIA; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS;

EID: 74549163750     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.77     Document Type: Article

References (36)

1. Pfaller MA, Jones RN, Marshall SA, Coffman SL, Hollis RJ, Edmond MB, Wenzel RP (1997) Inducible amp C betalactamase producing gram-negative bacilli from blood stream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE). Diagn Microbiol Infect Dis 28: 211-219.
2. Livermore DM (1995) beta-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 8: 557-584.
3. Matagne A, Dubus A, Galleni M, Frere JM (1999) The beta-lactamase cycle: a tale of selective pressure and bacterial ingenuity. Nat Prod Rep 16: 1-19.
4. Gangoue-Pieboji J, Bedenic B, Koulla-Shiro S, Randegger C, Adiogo D, Ngassam P, Ndumbe P, Hachler H (2005) Extended-spectrum-beta-lactamase-producing Enterobacteriaceae in Yaounde, Cameroon. J Clin Microbiol 43: 3273-3277.
5. Gangoue-Pieboji J, Koulla-Shiro S, Ngassam P, Adiogo D, Ndumbe P (2006) Antimicrobial activity against gram negative bacilli from Yaounde Central Hospital, Cameroon. Afr Health Sci 6: 232-235.
6. Gangoue-Pieboji J, Miriagou V, Vourli S, Tzelepi E, Ngassam P, Tzouvelekis LS (2005) Emergence of CTX-M-15-producing enterobacteria in Cameroon and characterization of a blaCTX-M-15-carrying element. Antimicrob Agents Chemother 49: 441-443.
7. Pieboji JG, Koulla-Shiro S, Ngassam P, Adiogo D, Njine T, Ndumbe P (2004) Antimicrobial resistance of Gram-negative bacilli isolates from inpatients and outpatients at Yaounde Central Hospital, Cameroon. Int J Infect Dis 8: 147-154.
8. Anon (2002) Traditional Medecine Strategy 2002-2005. Edited by WHO/EDM/TRM. World Health Organization: Geneva 74p.
9. Adjanohoun EJ, Aboubakar N, Dramane K, Ebot ME, Ekpere JA, Enow-Orock EG, Focho D, Gbilé ZO, Kamanyi A, Kamsu Kom J, Keita A, Mbenkum T, Mbi CN, Mbiele AL, Mbome IL, Mubiru NK, Nancy WL, Nkongmeneck B, Satabie B, Sofowora A, Tamze V, Wirmum CK (1996) Contribution to ethnobotanical and floristic studies in Cameroon. In Scientific Technical and Research Commission/Organization of African Unity. Cameroon. 641.
10. Gangoue-Pieboji J, Pegnyemb DE, Niyitegeka D, Nsangou A, Eze N, Minyem C, Mbing JN, Ngassam P, Tih RG, Sodengam BL Bodo B (2006) The in-vitro antimicrobial activities of some medicinal plants from Cameroon. Ann Trop Med Parasitol 100: 237-243.
11. Gangoue-Pieboji J, Baurin S, Frere JM, Ngassam P, Ngameni B, Azebaze A, Pegnyemb DE, Watchueng J, Goffin C, Galleni M (2007) Screening of some medicinal plants from Cameroon for beta-lactamase inhibitory activity. Phytother Res 21: 284-287.
12. Farmer JJ, III (1999) Enterobacteriaceae: introduction and identification. In: Manual of clinical microbiology. Edited by Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, 7 edn. Washington, D.C.: American Society for Microbiology. 442-458.
13. Jarlier V, Nicolas MH, Fournier G, Philippon A (1988) Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 10: 867-878.
14. 7). Wayne, PA: National Committee for Clinical Laboratory Standards.
15. 7), Wayne, PA: National Committee for Clinical Laboratory Standards.
16. Gangoue-Pieboji J (2007) Caractérisation des beta-lactamases et leur inhibition par les extraits de plantes médicinales. Doctorat. Liège: Université de Liège 127p.
17. Jacoby GA (1997) Extended-spectrum beta-lactamases and other enzymes providing resistance to oxyimino-beta-lactams. Infect Dis Clin North Am 11: 875-887.
18. Janssen AM, Scheffer JJ, Baerheim Svendsen A (1987) Antimicrobial activity of essential oils: a 1976-1986 literature review. Aspects of the test methods. Planta Med 53: 395-398.
19. Rios JL, Recio MC, Villar A (1988) Screening methods for natural products with antimicrobial activity: a review of the literature. J Ethnopharmacol 23: 127-149.
20. Ogundipe OO, Moody JO, Fakeye TO, Ladipo OB (2000) Antimicrobial activity of Mallotus oppositifolius extractives. Afr J Med Med Sci 29: 281-283.
21. Shan B, Cai YZ, Brooks JD, Corke H (2007) The in vitro antibacterial activity of dietary spice and medicinal herb extracts. Int J Food Microbiol 117: 112-119.
22. Vouffo B, Hussain H, Eyong KO, Dongo E, Folefoc GN, Nkengfack AE, Krohn K (2008) Chemical constituents of Dorstenia picta and Newbouldia laevis. Biochemical Systematics and Ecology 36: 730-732.
23. Iwu M, Diop AD, Messerole L, Okunji CO (2002) Garcinia kola: a new look at an old adaptogenic agent. Adv Phytomed 1: 191-199.
24. Terashima K, Kondo Y, Aqil M, Niwa M (1999) A new xanthone from stems of Garcinia kola. Nat Prod Lett 14: 91-97.
25. Fotie J, Bohle DS, Olivier M, Adelaida Gomez M, Nzimiro S (2007) Trypanocidal and antileishmanial dihydrochelerythrine derivatives from Garcinia lucida. J Nat Prod 70: 1650-1653.
26. Guedje NM (2002) La gestion des populations d'arbres comme outil pour une exploitation durable des produits forestiers non ligneux: l'exemple de Garcinia lucida (Sud-Cameroun). Bruxelles: Université Libre de Bruxelles. 223p.
27. Nyemba AM, Pondo TN, Connolly JD, Rycroft DS (1990) Cycloarthane derivatives from Garcinia lucida. Phytochemistry 29: 994-997.
28. Kouam SF, Flörke U, Krohm K, Akhtar MN, Ngadjui BT, Abegaz BM (2005) 2-β-taraxerol from Bridelia micrantha. Acta Crystallogr, 61: 599-600.
29. Pegel KH, Rogers CB (1968) Constituents of Bridelia micrantha. Phytochemistry 7: 655-656.
30. Gurib-Fakim A (2006) Medicinal plants: traditions of yesterday and drugs of tomorrow. Mol Aspects Med 27: 1-93.
31. Abo KA, Ashidi JS (1999) Antimicrobial screening of Bridelia micrantha, Alchormea cordifolia and Boerhavia diffusa. Afr J Med Med Sci 28: 167-169.
32. Lin J, Puckree T, Mvelase TP (2002) Anti-diarrhoeal evaluation of some medicinal plants used by Zulu traditional healers. J Ethnopharmacol 79: 53-56.
33. Samie A, Obi CL, Bessong PO, Namrita L (2005) Activity profiles of fourteen selected medicinal plants from Rural Venda communities in South Africa against fifteen clinical bacterial species. Afr J Biotechnol 4: 1443-1451.
34. Steenkamp V, Mokoele TL, Van Rensburg CEJ (2009) Toxicity Testing of Two Medicinal Plants, Bridelia micrantha and Antidesma venosum. Open Toxicol J 3: 35-38.
35. Ahmad I, Aqil F (2007) In vitro efficacy of bioactive extracts of 15 medicinal plants against ESbeta-lactamase-producing multidrug-resistant enteric bacteria. Microbiol Res 162: 264-275.
36. Si H, Hu J, Liu Z, Zeng ZL (2008) Antibacterial effect of oregano essential oil alone and in combination with antibiotics against extended-spectrum beta-lactamase-producing Escherichia coli. FEMS Immunol Med Microbiol 53: 190-194.